|
Volumn 92, Issue 6, 2003, Pages 653-654
|
The role of anti-androgen monotherapy in the treatment of prostate cancer [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIANDROGEN;
BICALUTAMIDE;
PLACEBO;
PROSTATE SPECIFIC ANTIGEN;
ADVANCED CANCER;
CANCER ADJUVANT THERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG COST;
EARLY CANCER;
HORMONE RESISTANCE;
HORMONE SENSITIVITY;
HUMAN;
INVESTMENT;
LETTER;
MONOTHERAPY;
PRESCRIPTION;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY OF LIFE;
TUMOR DIFFERENTIATION;
|
EID: 0142060690
PISSN: 14644096
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1464-410X.2003.t01-2-04442.x Document Type: Letter |
Times cited : (2)
|
References (3)
|